Study Start Up Specialist

The Opportunity
You know that the quality of a study is often decided before the first patient is enrolled. This role puts you exactly at that pivotal moment-where careful thinking, strong relationships, and attention to detail set the entire trajectory.

You'll join a globally active, science-driven biotech that's expanding its clinical footprint in North America. The pipeline is real, the science is differentiated, and the leadership team is hands-on. Rather than being one cog in a large machine, you'll work closely with clinical leaders who value initiative and trust good judgment.

This is a chance to step into a role where your work is visible early and matters immediately. You won't just support study start-up-you'll help shape how it's done as the organization grows.

What You'll Be Doing

• Set studies up for success by identifying the right sites and building early partnerships that last through the trial
• Drive momentum from feasibility through site activation, ensuring timelines are realistic-and met
• Act as a steady, informed point of contact for sites, vendors, and internal teams during the most critical early phase
• Bring clarity to regulatory and documentation processes, keeping everything inspection-ready from day one
• Spot friction early and resolve it practically, so studies start smoothly and stay on track

What You'll Bring

• Experience in clinical research or study start-up, ideally within biotech, pharma, or CRO settings
• Exposure to site feasibility, regulatory submissions, or site activation activities
• Familiarity with GCP and the practical realities of running compliant studies
• Confidence working with sites and cross-functional teams, both internally and externally
• A structured, detail-oriented approach, balanced with the ability to keep the bigger picture in mind
• Ideally, comfort in a growing organization where processes are evolving and your input is valued

What You'll Get

• Direct exposure to experienced clinical leaders-your work is seen and recognized
• The chance to influence how study start-up is built in a scaling biotech, not just follow existing playbooks
• A hybrid working model with meaningful in-office collaboration
• A scientifically credible environment where the work connects directly to improving patient outcomes